Lower Respiratory Tract Infection by Stenotrophomonas maltophilia in ICU: A Clinical and Drug Sensitivity Analysis

殷少军,何礼贤,胡必杰,瞿介明,倪才妹,周春妹,贾曼琳,周昭彦
DOI: https://doi.org/10.3321/j.issn:1005-4529.2003.12.032
2003-01-01
Abstract:OBJECTIVE To investigate the clinical characteristic and drug sensitivity status of lower respiratory tract infection by Stenotrophomonas maltophilia in intensive care unit(ICU), in order to provide essential basis for preventing and treating it. METHODS Retrospective survey of the clinical data of 68 cases with lower respiratory tract infection by S.maltophilia during Jan 1996 to Dec 2000,including the drug sensitivity results was conducted. RESULTS Critical underlying diseases(100%), decreased immunological function(83.1%), tracheal cannula and tracheotomy(78.6%), broad-spectrum antibiotics use for a long time(100%) were the primary risk factors related to the lower respiratory tract infection by S. maltophilia in ICU. The drug sensitivity tests results showed that S.maltophilia were multi-resistant to the first and second generations cephalosporins, the highest resistant to imipenem, but S.maltophilia was sensitive to ticarcillin sodium/potassium clavulanate (77.2%), ciprofloxacin (64.7%), and ceftazidime(60.7%). CONCLUSIONS The main risk factors of the lower respiratory tract infection by S.maltophilia in ICU are critical underlying diseases and long-term inappropriate use of broad-spectrum antibiotics. S.maltophilia is multi-drug resistant. Ticarcillin sodium /potassium clavulanate,ciprofloxacin, and ceftazidime are the effective antibiotics against S.maltophilia.
What problem does this paper attempt to address?